Two new antivirals for HIV will be approved soon
December 1996
Two new antivirals for HIV will be approved soon...Rescriptor (delavirdine) and Viracept (nelfinavir).
Rescriptor will be the second non-nucleoside reverse transcriptase inhibitor (NNRTI)...similar to Viramune (nevirapine).
The NNRTIs aren't as powerful as the protease inhibitors. But they have a niche in combo therapy...by boosting the efficacy of nucleosides such as AZT (Retrovir), 3TC (Epivir), etc.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote